Anthony A. Amato

Active 1994–2024

91
Papers
19,052
Citations
73
h-index
91
i10-index

Citations

Citations per year for Anthony A. Amato1988: 1 citations1994: 1 citations1995: 2 citations1996: 4 citations1997: 10 citations1998: 8 citations1999: 17 citations2000: 32 citations2001: 40 citations2002: 41 citations2003: 47 citations2004: 32 citations2005: 41 citations2006: 52 citations2007: 82 citations2008: 84 citations2009: 119 citations2010: 167 citations2011: 158 citations2012: 109 citations2013: 139 citations2014: 151 citations2015: 136 citations2016: 141 citations2017: 126 citations2018: 196 citations2019: 522 citations2020: 588 citations2021: 607 citations2022: 578 citations2023: 326 citations2024: 563 citations2025: 231 citations2026: 4 citations1989–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,641 citing papers, 25.4% of this breakdownUnited Kingdom: 491 citing papers, 7.6% of this breakdownItaly: 435 citing papers, 6.7% of this breakdownFrance: 395 citing papers, 6.1% of this breakdownChina: 352 citing papers, 5.5% of this breakdownGermany: 337 citing papers, 5.2% of this breakdownJapan: 257 citing papers, 4% of this breakdownCanada: 244 citing papers, 3.8% of this breakdownNetherlands: 231 citing papers, 3.6% of this breakdownSpain: 199 citing papers, 3.1% of this breakdownAustralia: 181 citing papers, 2.8% of this breakdownSweden: 131 citing papers, 2% of this breakdown
0%25.4%Other 24.2%

Fields

  • Medicine72%
  • Biochemistry, Genetics and Molecular Biology22.9%
  • Neuroscience1.9%
  • Immunology and Microbiology1.9%
  • Engineering0.3%
  • Health Professions0.2%
  • Other0.8%

Topics

  • Inflammatory Myopathies and Dermatomyositis9.7%
  • Muscle Physiology and Disorders6.9%
  • Peripheral Neuropathies and Disorders5.6%
  • Myasthenia Gravis and Thymoma3.9%
  • Parkinson's Disease and Spinal Disorders3.5%
  • Long-Term Effects of COVID-192.3%
  • Other68.1%

Coauthors

All papers

Open in search
  1. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider - Annals of the Rheumatic Diseases 2017 cited by 1,525

  2. 224th ENMC International Workshop:

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Neuromuscular Disorders 2017 cited by 554

  3. Randomized Trial of Thymectomy in Myasthenia Gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Guillermo Ramos, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Robin Conwit, Joanne Odenkirchen, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter - New England Journal of Medicine 2016 cited by 905

  4. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bianca Santomasso, Ryan J. Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L. Reynolds - Journal for ImmunoTherapy of Cancer 2021 cited by 215

  5. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

    Authors: , , , , , , , , - Neuromuscular Disorders 2004 cited by 937

  6. Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Vaccine 2010 cited by 650

  7. Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis

    Authors: , , , , , , , , , , , - Annals of Neurology 2005 cited by 612

  8. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mazen M. Dimachkie, Erik Ensrud, Floranne C. Ernste, D. Gareth Evans, Manabu Fujimoto, Ignacio García‐De La Torre, Abraham García-Kutzbach, Zoltán Griger, Latika Gupta, Marie Hudson, Florenzo Iannone, David Isenberg, Joseph L. Jorizzo, Helen Kurtz, Masataka Kuwana, Vidya Limaye, Ingrid E. Lundberg, Andrew L. Mammen, H. Mann, Frank Mastaglia, Lorna McWilliams, Christopher A. Mecoli, Federica Meloni, Frederick W. Miller, Siamak Moghadam‐Kia, Sergey Moiseev, Yoshinao Muro, Melinda Nagy‐Vincze, Clive Nayler, Merrilee Needham, Ichizo Nishino, Chester V. Oddis, Julie J. Paik, Joost Raaphorst, Lisa G. Rider, Jorge Rojas‐Serrano, Lesley Ann Saketkoo, Adam Schiffenbauer, Samuel Katsuyuki Shinjo, Vineeta Shobha, Yeong‐Wook Song, Tania Tillett, Yves Troyanov, Anneke J. van der Kooi, Mónica Vázquez-Del Mercado, Jiří Vencovský, Qian Wang, Steven R. Ytterberg, Rohit Aggarwal - Nature Reviews Rheumatology 2023 cited by 139

  9. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Nicholas J. Silvestri, Robin Conwit, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter, Gary Cutter, Inmaculada Aban, Greg Minisman, Michelle Feese, Hui‐Chien Kuo, John Newsom–Davis, Gil I. Wolfe, Henry J. Kaminski, Alfred Jaretzki, Joshua Sonett, Claudio Mazia, Valeria Saluto, Moisés Rosenberg, Valeria Alvarez, Lisa A. Rocca Rey, John King, Helmut Butzkueven, John Goldblatt, John C. Carey, John R. Pollard, Stephen Reddel, Nicholas Handel, Brian C. McCaughan, Linda Pallot, Márcia Waddington‐Cruz, Ricardo Novis, Carlos Henrique Ribeiro Boasquevisque, Elza Dias‐Tosta, Rubens N. Morato-Fernandez, Manoel Ximenes, Lineu César Werneck, Rosana Hermínia Scola, Paulo Soltoski, Colin Chalk, Fraser Moore, David S. Mulder, Lisa Wadup, Joël Oger, Michele Mezei, Kenneth G. Evans, Theresa Jiwa, Anne Schaffar, Chris White, Cory Toth, Gary Gelfand, Susan P. Wood, Elizabeth Pringle, Jocelyn Zwicker, Donna E. Maziak, Farid M. Shamji, Sudhir Sundaresan, Andrew Seely and 247 more - The Lancet Neurology 2019 cited by 223

  10. Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2021 cited by 134

  11. Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies

    Authors: , , , , , , , , , , - Neurology 2019 cited by 167

  12. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aziz Shaibani, Kumaraswamy Sivakumar, Namita Goyal, Madoka Mori‐Yoshimura, Satoshi Yamashita, Naoki Suzuki, Masahisa Katsuno, Kenya Murata, Hiroyuki Nodera, Ichizo Nishino, Carla D Romano, Valerie Williams, John Vissing, Lixin Zhang Auberson, Min Wu, Ana de Vera, Dimitris A. Papanicolaou, Anthony A. Amato - The Lancet Neurology 2019 cited by 133

  13. Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis

    Authors: , , , , , , , , - Arthritis & Rheumatism 2007 cited by 304

  14. Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis

    Authors: , , , , , , , , , , - Annals of Neurology 2012 cited by 286

  15. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anneke van der Kooi, Yves Allenbach, Matthew Appleby, Richard J Barohn, Nicolas Champtiaux, Christopher Doughty, Jerrica Farias, Constantine Farmakidis, Ali A. Habib, Chafic Karam, James Lilleker, Samantha Lorusso, Mamatha Pasnoor, Iago Pinal-Fernandez, Giorgia Querin, Joost Raaphorst, George Ransley, Sami Saba, Kazim Sheikh, Andrew Snedden, Jeffrey Statland, Tuan Vu - The Lancet Rheumatology 2023 cited by 55

  16. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 1998 cited by 919

  17. A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2008 cited by 468

  18. Treatment of sporadic inclusion body myositis with bimagrumab

    Authors: , , , , , , , , , , , , - Neurology 2014 cited by 206

  19. Interferon‐stimulated gene 15 ( ISG15 ) conjugates proteins in dermatomyositis muscle with perifascicular atrophy

    Authors: , , , , , , , , , , , , , , - Annals of Neurology 2009 cited by 193

  20. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 cited by 169

  21. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis

    Authors: , , , , , , , , , , , , - Genes and Immunity 2011 cited by 148

  22. Highly differentiated cytotoxic T cells in inclusion body myositis

    Authors: , , , , , - Brain 2019 cited by 131

  23. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandhya Sasidharan, Melissa Currence, Todd Levine, Rebecca Otutoa, Angelina Cooper, Tahseen Mozaffar, Ali A. Habib, Jonathan Cauchi, Shannon Ung, Veena Mathew, Isela Hernandez, Summer Gibson, Mark B. Bromberg, Kyle Mahoney, Crystal Neate, Teresa Janecki, Mike Papadakis, Miriam Freimer, MacKenzie Kaschalk, Sarah Heintzman, Matthew Wicklund, Brenna Baines, Alexa Vareldzis, Emily Hyslop, Brianna Blume, Emma Ciafaloni, Elizabeth Luebbe, Katy Eichinger, William Martens, Stephanie Gregory, Joanne Janciuras, Anthony A. Amato, Christopher Doughty, Kristen Roe, Patricia M. Flynn, Emily Russo, Thomas E. Lloyd, Jemima Albayda, Eleni Tiniakou, Simone Thomas, Sarah Jones, Guillermo Solórzano, Matthew Elliott, Ted M. Burns, Allison Crowell, Deborah Eggleston, Mary Wagoner, Aziz Shaibani, Chantae Oates, Pedro Machado, Michael G. Hanna, Linda Greensmith, Mhoriam Ahmed, Vinojini Vivekanandam, Matthew Appleby, George Ransley, Edwin Eshun, Iwona Skorupinska, Louise Germain, Ana Marie Laxa, Joana Roca Pontes, Anna Bellin, Dolapo Anifowoshe - The Lancet Neurology 2023 cited by 34

  24. Evaluation and construction of diagnostic criteria for inclusion body myositis

    Authors: , , , , , - Neurology 2014 cited by 248